Barclays reports 1.27% stake in PHIBRO

Barclays PLC filed an amended Schedule 13G/A reporting beneficial ownership of 263,695 shares of Phibro Animal Health Corp-A common stock, representing 1.27% of the class.

Rhea-AI Filing Summary

Barclays PLC filed an amended Schedule 13G/A reporting beneficial ownership of 263,695 shares of Phibro Animal Health Corp-A common stock, representing 1.27% of the class. The filing shows Barclays has sole voting and sole dispositive power over the reported shares. The amendment is signed by a Barclays director on 05/14/2026.

Key Figures

Filing type: Schedule 13G/A Beneficially owned: 263,695 shares Percent of class: 1.27% +4 more

7 metrics

Filing type Schedule 13G/A Amendment No. 1

Beneficially owned 263,695 shares Common stock

Percent of class 1.27% Reported ownership percentage

CUSIP 71742Q106 Phibro Animal Health Corp-A

Sole voting power 263,695 shares Item 4(i)

Sole dispositive power 263,695 shares Item 4(iii)

Signature date 05/14/2026 Signature by Barclays director

Key Terms

Schedule 13G/A, beneficially owned, sole dispositive power, parent holding company

4 terms

Schedule 13G/A regulatory

"filed an amended Schedule 13G/A reporting beneficial ownership"

A Schedule 13G/A is an amended public filing with the U.S. securities regulator that updates a previous Schedule 13G, disclosing when an individual or group holds a substantial (typically over 5%) stake in a company and is claiming a passive, non‑controlling intent. Investors monitor these updates because rising or falling holdings can signal changing confidence, potential future moves, or shifts in voting power — like watching a public ledger where large shareholders quietly adjust their positions.

beneficially owned financial

"Amount beneficially owned: 263695"

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

sole dispositive power regulatory

"Sole power to dispose or to direct the disposition of: 263695"

Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.

parent holding company regulatory

"Identification and Classification of the Subsidiary Which Acquired the Security"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What stake does Barclays PLC report in PHIBRO (PAHC)?

Barclays PLC reports beneficial ownership of 263,695 shares, equal to 1.27% of PHIBRO common stock. The filing is an amended Schedule 13G/A and lists sole voting and dispositive power over those shares.

Does the filing indicate who has voting or dispositive power for PAHC shares?

Yes. The amendment lists sole voting power and sole dispositive power of 263,695 shares for Barclays PLC. Shared voting or dispositive power is reported as 0 in the filing.

When was the Schedule 13G/A for PAHC signed by Barclays?

The Schedule 13G/A amendment is signed by a Barclays director with a signature date of 05/14/2026. The filing header also references 03/31/2026 in the document metadata.

Which Barclays entities are identified in the filing for the PAHC position?

The filing names affiliated entities including Barclays Bank PLC, Barclays Capital Inc, and Barclays Capital Securities Ltd as relevant subsidiaries or broker-dealer affiliates in Item 7.

What CUSIP and class are reported for the PHIBRO holding?

The filing reports the CUSIP 71742Q106 and identifies the security as Common Stock of Phibro Animal Health Corp-A. The Schedule 13G/A format is used for passive or qualifying institutional holdings.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/14/2026 - 08:48 PM Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 1)

PHIBRO ANIMAL HEALTH CORP-A

(Name of Issuer)

COMMON-STOCK

(Title of Class of Securities)

71742Q106

(CUSIP Number)

03/31/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 71742Q106

1

Names of Reporting Persons

Barclays PLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED KINGDOM

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 263,695.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 263,695.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

263,695.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

1.27 %

12

Type of Reporting Person (See Instructions)

HC

SCHEDULE 13G

Item 1.
(a)	Name of issuer: PHIBRO ANIMAL HEALTH CORP-A
(b)	Address of issuer's principal executive offices: Glenpointe Centre East, 3rd Floor
Item 2.
(a)	Name of person filing: Barclays PLC
(b)	Address or principal business office or, if none, residence: 1 Churchill Place, London - E14 5HP
(c)	Citizenship: X0
(d)	Title of class of securities: COMMON-STOCK
(e)	CUSIP No.: 71742Q106
Item 4.	Ownership
(a)	Amount beneficially owned: 263695
(b)	Percent of class: 1.27 %
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 263695
	(ii) Shared power to vote or to direct the vote: 0
	(iii) Sole power to dispose or to direct the disposition of: 263695
	(iv) Shared power to dispose or to direct the disposition of: 0
Item 5.	Ownership of 5 Percent or Less of a Class.
	Ownership of 5 percent or less of a class
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	If a parent holding company has filed this schedule, pursuant to Rule 13d-1(b)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary. Barclays Bank PLC, Barclays Capital Inc, Barclays Capital Securities Ltd
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Barclays PLC

Signature:	Ramya Rao
Name/Title:	Director
Date:	05/14/2026